Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | IDA | CHRD |
|---|---|---|
| Price | $131.73 | $139.11 |
| Change today | ▼ 0.80% | ▲ 1.53% |
| Market cap | $7.62B | $7.61B |
| Return, 3 months | -12.6% | +20.1% |
| Return, year to date | +6.1% | +54.3% |
| Return, 1 year | +1.1% | +45.6% |
| P/E (TTM) | 21.8 | 9.4 |
| P/B | 2.0 | 0.9 |
| P/E percentile vs own 5y | – | – |
| Dividend yield | 2.66% | 3.74% |
| Revenue growth (YoY, latest qtr) | – | – |
| Net profit growth (YoY) | – | – |
| Gross margin | – | – |
| Operating margin | – | – |
| Net margin | – | – |
| Return on equity | – | – |
| Analyst target vs. price | – | – |
| Analyst buy share | – | – |
| RSI (14) | 44 | 47 |
| 30-day volatility | 14.4% | 34.7% |
| Max drawdown, 1 year | -16.9% | -24.8% |
| Trend read | Strong downtrend | Leaning bearish |
| Analyst consensus | – | – |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
